Drug Cuts: Oncologists Face Steep Drug Cuts, But Will Practice Expenses Compensate?

Article Overview

This article explains how a new Medicare reform bill changes drug payment methodology over time and examines related payment issues for oncology practices. It covers broad updates to drug pricing, competitive acquisition demonstrations, practice expense valuation for drug administration, and HHS review of billing and reporting policies. The piece is relevant to oncologists, medical coders, billing staff, and practice administrators following Medicare reimbursement policy.